Literature DB >> 19660467

Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity.

Ling Gao1, Karel Chalupsky, Enrico Stefani, Hua Cai.   

Abstract

Folate supplementation improves endothelial function in patients with hyperhomocysteinemia. Mechanistic insights into potential benefits of folate on vascular function in general population however, remain mysterious. Expression of dihydrofolate reductase (DHFR) was markedly increased by folic acid (FA, 50 micromol/L, 24 h) treatment in endothelial cells. Tetrahydrofolate (THF) is formed after incubation of purified DHFR or cellular extracts with 50 micromol/L of substrate dihydrofolic acid. THF could then be detected and quantified by high performance liquid chromatography (HPLC) with a fluorescent detector (295/365 nm). Using this novel and sensitive assay, we found that DHFR activity was significantly increased by FA. Furthermore, FA improved redox status of Ang II treated cells by increasing H(4)B and NO() bioavailability while decreasing superoxide (O(2)(-)) production. It however failed to restore NO() levels in DHFR siRNA-transfected or methotrexate pre-treated cells, implicating a specific and intermediate role of DHFR. In mice orally administrated with FA (15 mg/kg/day, 16 days), endothelial upregulation of DHFR expression and activity occurred in correspondence to improved NO() and H(4)B bioavailability, and this was highly effective in reducing Ang II infusion (0.7 mg/kg/day, 14 days)-stimulated aortic O(2)(-) production. 5'-methyltetrahydrofolate (5'-MTHF) levels, GTPCH1 expression and activity remained unchanged in response to FA or Ang II treatment in vitro and in vivo. FA supplementation improves endothelial NO() bioavailability via upregulation of DHFR expression and activity, and protects endothelial cells from Ang II-provoked oxidant stress both in vitro and in vivo. These observations likely represent a novel mechanism (intermediate role of DHFR) whereby FA induces vascular protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660467      PMCID: PMC2784291          DOI: 10.1016/j.yjmcc.2009.07.025

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  39 in total

1.  Key references: Homocysteine and atherothrombotic vascular disease.

Authors:  J Loscalzo
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Folic acid in endothelial function in familial hypercholesterolemia.

Authors:  M F Bellamy; I F McDowell; M J Lewis
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

3.  Rapid method for the determination of total 5-methyltetrahydrofolate in blood by liquid chromatography with fluorescence detection.

Authors:  Wenhong Lu; Hui Li; Yuan Zhang; Catharina Y W Ang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-01-25       Impact factor: 3.205

4.  Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.

Authors:  S Yap; G H Boers; B Wilcken; D E Wilcken; D P Brenton; P J Lee; J H Walter; P M Howard; E R Naughten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

5.  Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.

Authors:  Norbert Weiss; Stanley Heydrick; Ying-Yi Zhang; Charlene Bierl; André Cap; Joseph Loscalzo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

6.  Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

Authors:  S N Doshi; I F McDowell; S J Moat; D Lang; R G Newcombe; M B Kredan; M J Lewis; J Goodfellow
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

Review 7.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

Authors:  H Cai; D G Harrison
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

8.  Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine.

Authors:  J C Chambers; P M Ueland; O A Obeid; J Wrigley; H Refsum; J S Kooner
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

9.  Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability.

Authors:  Ling Gao; Yuh-Fen Pung; Jun Zhang; Peng Chen; Ting Wang; Min Li; Miguel Meza; Ligia Toro; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

10.  Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones.

Authors:  M Bauer; S Suppmann; M Meyer; C Hesslinger; T Gasser; H R Widmer; M Ueffing
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

View more
  51 in total

1.  Reply: To PMID 25882860.

Authors:  Qiang Li; Ji-Youn Youn; Shan Li; Hua Cai
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

2.  Differential Roles of Protein Complexes NOX1-NOXO1 and NOX2-p47phox in Mediating Endothelial Redox Responses to Oscillatory and Unidirectional Laminar Shear Stress.

Authors:  Kin Lung Siu; Ling Gao; Hua Cai
Journal:  J Biol Chem       Date:  2016-01-29       Impact factor: 5.157

3.  Novel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative Stress.

Authors:  Hong Li; Qiang Li; Yixuan Zhang; Wenting Liu; Bo Gu; Taro Narumi; Kin Lung Siu; Ji Youn Youn; Peiqing Liu; Xia Yang; Hua Cai
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

4.  Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.

Authors:  Kin Lung Siu; Christopher Lotz; Peipei Ping; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2014-07-24       Impact factor: 5.000

Review 5.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

6.  Induction of cardioprotection by small netrin-1-derived peptides.

Authors:  Qiang Li; Hua Cai
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-29       Impact factor: 4.249

Review 7.  Surviving With Smog and Smoke: Precision Interventions?

Authors:  Hua Cai; Chen Wang
Journal:  Chest       Date:  2017-07-08       Impact factor: 9.410

Review 8.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

Review 9.  Molecular mechanisms underlying the potentially adverse effects of folate.

Authors:  Kyle C Strickland; Natalia I Krupenko; Sergey A Krupenko
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

10.  NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish.

Authors:  Yixuan Zhang; Hirohito Shimizu; Kin Lung Siu; Aman Mahajan; Jau-Nian Chen; Hua Cai
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.